Explore

Trendline Trendline
Biogen's Alzheimer's Results Support Tau Theory, Boosting Denali's Prospects

Biogen's Alzheimer's Results Support Tau Theory, Boosting Denali's Prospects

Biogen's Alzheimer's Results Support Tau Theory, Boosting Denali's Prospects
Trendline Trendline
Atisama Therapeutics Advances RB042 in Phase 1 Trial, Appoints New Board Chair

Atisama Therapeutics Advances RB042 in Phase 1 Trial, Appoints New Board Chair

Atisama Therapeutics Advances RB042 in Phase 1 Trial, Appoints New Board Chair
Trendline Trendline
Atisama Therapeutics Advances RB042 in Phase 1 Trial and Appoints New Board Chair

Atisama Therapeutics Advances RB042 in Phase 1 Trial and Appoints New Board Chair

Atisama Therapeutics Advances RB042 in Phase 1 Trial and Appoints New Board Chair
Trendline Trendline
PepGen Reports Positive Progress in FREEDOM2-DM1 Trial with Financial Stability

PepGen Reports Positive Progress in FREEDOM2-DM1 Trial with Financial Stability

PepGen Reports Positive Progress in FREEDOM2-DM1 Trial with Financial Stability
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Trendline Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Immunome Advances Cancer Therapy Pipeline with New Drug Application and Clinical Trials

Immunome Advances Cancer Therapy Pipeline with New Drug Application and Clinical Trials

Immunome Advances Cancer Therapy Pipeline with New Drug Application and Clinical Trials
Trendline Trendline
Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials

Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials

Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials
Trendline Trendline
FDA Places Partial Clinical Hold on PepGen's FREEDOM2 Study Amid Safety Concerns

FDA Places Partial Clinical Hold on PepGen's FREEDOM2 Study Amid Safety Concerns

FDA Places Partial Clinical Hold on PepGen's FREEDOM2 Study Amid Safety Concerns
Trendline Trendline
Biogen's Alzheimer's Drug Results Support Tau Theory, Boosting Denali's Prospects

Biogen's Alzheimer's Drug Results Support Tau Theory, Boosting Denali's Prospects

Biogen's Alzheimer's Drug Results Support Tau Theory, Boosting Denali's Prospects
Trendline Trendline
Biogen Advances Alzheimer's Drug Diranersen Despite Phase 2 Trial Setback

Biogen Advances Alzheimer's Drug Diranersen Despite Phase 2 Trial Setback

Biogen Advances Alzheimer's Drug Diranersen Despite Phase 2 Trial Setback
Trendline Trendline
Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases

Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases

Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases